Yüklüyor......
Targeting the tumor mutanome for personalized vaccination therapy
Next generation sequencing enables identification of immunogenic tumor mutations targetable by individualized vaccines. In the B16F10 melanoma system as pre-clinical proof-of-concept model, we found a total of 563 non-synonymous expressed somatic mutations. Of the mutations we tested, one third were...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3429589/ https://ncbi.nlm.nih.gov/pubmed/22934277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.19727 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|